Skip to content
SIRUM logo

SIRUM

SIRUM is a YC Winter 2015 (W15) company. Based in Palo Alto, CA, USA. Team of 15.

  • Consumer Health Services
  • Nonprofit

About SIRUM

GPAgent's own fund-neutral profile, written from public information. Updated Oct 4, 2026.

Summary

SIRUM connects surplus medicine, from nursing homes, pharmacies, manufacturers, and individuals, to safety-net clinics and community partners serving patients who cannot afford their prescriptions. Its technology platform matches donated, unexpired drugs to the organizations that need them, replacing a process where billions of dollars of usable medicine is destroyed each year. SIRUM also advises county governments and drug donor groups on building compliant redistribution programs.

Go-to-market

Community health clinics and similar safety-net organizations sign up to receive donated medicine, while donors such as pharmacies, nursing homes, and manufacturers use SIRUM's platform to route surplus inventory rather than dispose of it.

From the Y Combinator listing

How SIRUM describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

SIRUM is a “match.com” for unused medicine. We connect institutional…

SIRUM uses technology to connect, prioritize and simplify various sources of medicine. We help safety-net clinics access this medicine for their patients. SIRUM is an innovative nonprofit organization committed to reducing barriers to health for underserved populations. Incubated at Stanford University, SIRUM draws from the academic and technology expertise of faculty and alumni to strengthen its impact and efficiency. SIRUM has become a leader in prescription drug donations, providing consulting and technical assistance to county governments, community clinics and multiple drug donor groups to establish redistribution programs

Facts

Industry
Unspecified / Unspecified
Location
Palo Alto, CA, USA
Team size
15
Status
Active
Stage
Early

Founders (3)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works